

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | EG1 is an inhibitor of Pax2 transcription activation with a small molecule that targets the DNA binding domain. |
| Concentration | Treated Time | Description | References | |
| ES-2 cells | 12.5 µM and 25 µM | 48 hours | EG1 significantly reduces cell viability and proliferation in Pax2 positive ovarian cancer cell lines | ACS Chem Biol. 2017 Mar 17;12(3):724-734 |
| TOV112D cells | 12.5 µM and 25 µM | 48 hours | EG1 significantly reduces cell viability and proliferation in Pax2 positive ovarian cancer cell lines | ACS Chem Biol. 2017 Mar 17;12(3):724-734 |
| RCC111 cells | 12.5 µM and 25 µM | 48 hours | EG1 significantly reduces cell viability and proliferation in Pax2 positive renal cancer cell lines | ACS Chem Biol. 2017 Mar 17;12(3):724-734 |
| HEK293 cells | 10 µM | overnight | EG1 inhibits Pax2 mediated luciferase reporter gene expression with an IC50 of approximately 10 µM | ACS Chem Biol. 2017 Mar 17;12(3):724-734 |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Embryonic kidney culture model | In vitro culture | increasing concentrations | 48 hours | EG1 inhibits branching morphogenesis and Pax2 target gene expression in kidney development | ACS Chem Biol. 2017 Mar 17;12(3):724-734 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.56mL 0.51mL 0.26mL |
12.81mL 2.56mL 1.28mL |
25.62mL 5.12mL 2.56mL |
|
| CAS号 | 693241-54-2 |
| 分子式 | C22H18N2O5 |
| 分子量 | 390.39 |
| SMILES Code | O=C(O)C1=CC=CC=C1NC(C2=CC=C(NC(C3=CC=CC=C3OC)=O)C=C2)=O |
| MDL No. | MFCD03624354 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | GYZZRJRJYVMXNS-UHFFFAOYSA-N |
| Pubchem ID | 2193203 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 85 mg/mL(217.73 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1